High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies
Conditions
- Drug/Agent Toxicity by Tissue/Organ
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
Interventions
- DRUG: cytarabine
- DRUG: deoxycytidine
Sponsor
Virginia Commonwealth University
Collaborators